As the only open-irrigated RF catheter with industrial diamonds to optimize power based on tissue surface temperature, the DiamondTemp™ ablation system (DTA) with RealTemp™ is safe and effective, and has demonstrated procedural efficiencies compared to contact force-sensing RF.1Product Details
The Arctic Front Advance™ and Arctic Front Advance Pro™ cardiac cryoablation catheters are approved in the United States to treat drug-refractory, recurrent, symptomatic, paroxysmal, and persistent atrial fibrillation (episode duration less than six months). The Arctic Front Advance and Arctic Front Advance Pro cardiac cryoablation catheters are also approved to treat recurrent, symptomatic, paroxysmal atrial fibrillation as an alternative to anti-arrhythmic drug therapy as an initial rhythm control strategy.
The catheters have a proven safety and efficacy profile in treating AF.2Product Details
The Achieve™ and Achieve Advance™ mapping catheters are intra-cardiac electrophysiology diagnostic catheters designed for use with the Arctic Front family of cardiac cryoablation catheters, the FlexCath™ Advance steerable sheath, and the CryoConsole™.Product Details
The CryoConsole houses the components and software needed to perform cryoablation procedures with the Arctic Front family of cardiac cryoablation catheters or the Freezor family of cardiac cryoablation catheters. It controls the delivery, recovery, and disposal of cryoablation refrigerant safely and efficiently.Product Details
The FlexCath advance steerable sheath is part of the Arctic Front cardiac cryoablation catheter system and is the only sheath that has been tested for use with the Arctic Front family of cardiac cryoablation catheters. It can also be used with the Freezor MAX cardiac cryoablation catheter.Product Details
Kautzner J, Albenque JP, Natale A, et al. A Novel Temperature-Controlled Radiofrequency Catheter Ablation System Used to Treat Patients With Paroxysmal Atrial Fibrillation. JACC Clin Electrophysiol. March 2021;7(3):352-363.
Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. April 23, 2013;61(16):1713-1723.